Genetic variants in TNFa, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthma
-
2016/01/01
-
Details
-
Personal Author:Bernstein DI ; Boulet L-P ; Cartier A ; Cruz M-J ; Fluharty K ; Gautrin D ; Johnson VJ ; Kashon ML ; Lummus ZL ; Luster MI ; Munoz X ; Quirce S ; Sastre J ; Tarlo SM ; Yucesoy, Berran
-
Description:Diisocyanates are the most common cause of occupational asthma, but risk factors are not well defined. A case-control study was conducted to investigate whether genetic variants in inflammatory response genes (TNFa, IL1a, IL1B, IL1RN, IL10, TGFB1, ADAM33, ALOX-5, PTGS1, PTGS2 and NAG-1/GDF15) are associated with increased susceptibility to diisocyanate asthma (DA). These genes were selected based on their role in asthmatic inflammatory processes and previously reported associations with asthma phenotypes. The main study population consisted of 237 Caucasian French Canadians from among a larger sample of 280 diisocyanate-exposed workers in two groups: workers with specific inhalation challenge (SIC) confirmed DA (DA+, n=95) and asymptomatic exposed workers (AW, n=142). Genotyping was performed on genomic DNA, using a 50 nuclease PCR assay. After adjusting for potentially confounding variables of age, smoking status and duration of exposure, the PTGS1 rs5788 and TGFB1 rs1800469 single nucleotide polymorphisms (SNP) showed a protective effect under a dominant model (OR=0.38; 95% CI=0.17, 0.89 and OR=0.38; 95% CI=0.18, 0.74, respectively) while the TNFa rs1800629 SNP was associated with an increased risk of DA (OR=2.08; 95% CI=1.03, 4.17). Additionally, the PTGS2 rs20417 variant showed an association with increased risk of DA in a recessive genetic model (OR=6.40; 95% CI=1.06, 38.75). These results suggest that genetic variations in TNFa, TGFB1, PTGS1 and PTGS2 genes contribute to DA susceptibility. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1547-691X
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:119-126
-
Volume:13
-
Issue:1
-
NIOSHTIC Number:nn:20046169
-
Citation:J Immunotoxicol 2016 Jan; 13(1):119-126
-
Contact Point Address:Dr. Berran Yucesoy, Division of Immunology, Allergy and Rheumatology, University of Cincinnati, College of Medicine, Cincinnati, OH
-
Email:berranyucesoy@gmail.com
-
Federal Fiscal Year:2016
-
NORA Priority Area:
-
Performing Organization:University of Cincinnati
-
Peer Reviewed:True
-
Start Date:20060901
-
Source Full Name:Journal of Immunotoxicology
-
End Date:20180831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:92372babaf70dcc0a5ed825b190c76fe526a57fa3a744226d53823eafe6c1d31f70b52e8f97429a1d289437c349544b800cc24da44f0fbfb1f8312a9de03d428
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like